Cantargia AB documents

Explore the latest documents from Cantargia AB, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.

Description

Event date

Documents and forms

2025

Investing in Life Science 2025

Sep 25, 2025

Transcript

Q2 2025

Aug 21, 2025

Interim report

Slides

Transcript

Q1 2025

May 13, 2025

Interim report

Slides

Transcript

2024

Q4 2024

Feb 21, 2025

Annual report

Interim report

Transcript

Q3 2024

Nov 15, 2024

Interim report

Q2 2024

Aug 28, 2024

Interim report

Q1 2024

May 21, 2024

Interim report

2023

Q4 2023

Feb 22, 2024

Annual report

Interim report

Slides

Q3 2023

Nov 10, 2023

Interim report

Q2 2023

Aug 22, 2023

Interim report

Q1 2023

May 23, 2023

Interim report

2022

Q4 2022

Feb 23, 2023

Annual report

Earnings release

Q3 2022

Nov 10, 2022

Interim report

Q2 2022

Aug 30, 2022

Interim report

Q1 2022

May 23, 2022

Interim report

2021

Q4 2021

Feb 24, 2022

Annual report

Earnings release

Q3 2021

Nov 11, 2021

Interim report

Q2 2021

Aug 19, 2021

Interim report

Q1 2021

May 26, 2021

Interim report

CMD 2021

May 20, 2021

Slides

2020

Q4 2020

Feb 25, 2021

Annual report

Interim report

2019

Q4 2019

Apr 30, 2020

Annual report

2018

Q4 2018

Apr 30, 2019

Annual report

2017

Q4 2017

May 9, 2018

Annual report